about
Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D studyA review of paediatric tuberculosis in Denmark: 10-year trend, 2000-2009.Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals.Are we successfully managing cardiovascular disease in people living with HIV?Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study.Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.Abacavir use and risk of recurrent myocardial infarction.Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study.Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.Associations between serum albumin and serious non-AIDS events among people living with HIV
P50
Q34474941-DE57F02A-6C8C-486B-971A-130D4EC4702BQ38132540-F6A0BF02-D0CB-48B6-A912-12D0B629ACCFQ38409305-34DEA5F1-246F-4A9E-B7D5-B79B83BF6002Q38612765-B29BB2EF-9306-4358-A4A0-86B929D41449Q40590600-BFAB5D09-69BF-4B29-9771-F35CD967D8D6Q47134347-E8FEF77C-074F-4D4F-A12A-F29CFBBF3D16Q47266595-1BCD8B48-3A7A-47ED-842A-0C82F4D35043Q48574265-62430078-FE1B-4158-9B39-3ADE5C849B7AQ51418184-F5D6D6E8-1F8D-4F9F-99B6-A2A19D7AB0C8Q54219925-85F6D11B-264C-4368-8F92-F6BBC426D615Q56243465-CDA9B15C-7433-4356-B795-C13160D2D9FA
P50
name
Camilla Ingrid Hatleberg
@ast
Camilla Ingrid Hatleberg
@en
Camilla Ingrid Hatleberg
@es
Camilla Ingrid Hatleberg
@nl
type
label
Camilla Ingrid Hatleberg
@ast
Camilla Ingrid Hatleberg
@en
Camilla Ingrid Hatleberg
@es
Camilla Ingrid Hatleberg
@nl
prefLabel
Camilla Ingrid Hatleberg
@ast
Camilla Ingrid Hatleberg
@en
Camilla Ingrid Hatleberg
@es
Camilla Ingrid Hatleberg
@nl